Davidson Kempner Capital Management LP Longboard Pharmaceuticals, Inc. Transaction History
Davidson Kempner Capital Management LP
- $4.36 Trillion
- Q4 2024
Shares
1 transactions
Others Institutions Holding LBPH
# of Institutions
4Shares Held
2.41MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY2.37MShares$142 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V825KShares$1.5 Million0.0% of portfolio
-
Raymond James & Associates St Petersburg, FL12.2KShares$731,7560.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ1.16KShares$69,4560.0% of portfolio
About Longboard Pharmaceuticals, Inc.
- Ticker LBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,586,000
- Market Cap $815M
- Description
- Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...